The taxpayer-funded ADHD boom
Financial Times
A review into the rising prevalence and diagnosis of ADHD is expected to conclude that other conditions are being misdiagnosed as ADHD, raising concerns about the overuse of ADHD medications and the potential misuse of taxpayer funds in treating the condition. The findings highlight a growing debate over the accuracy of ADHD diagnoses and the implications for public health spending.
All articles from 5 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.